Psychedelic Medicine

Association

Ketamine in Trauma: A Literature Review and Administration Guidelines

Excerpts from the publication

Ketamine is a phencyclidine (PCP) derivative, which primarily acts as a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. Ketamine serves as an analgesic and a dissociative sedative that produces potent analgesia, sedation, and amnesia while preserving spontaneous respiratory drive. It is rapidly gaining acceptance in the management of pain as multiple studies have demonstrated its reliable efficacy and a wide margin of safety. This article reviews some of these studies, the history of ketamine, and its pharmacological and pharmacokinetic properties. The article also discusses the use of ketamine in the trauma setting, including joint reductions, procedures, sedation, and pain control, as well as dosing recommendations.

Read more

Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression

Psychedelics therapeutics: What we know, what we think, and what we need to research

Acute mood-elevating properties of microdosed LSD in healthy volunteers: a home-administered randomised controlled trial

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression

Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs

Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial